Investing.com -- Maze Therapeutics, a clinical-stage biopharmaceutical company, launched its initial public offering (IPO) today, with shares starting to trade at $16.12. The company priced 8,750,000 ...
Facebook (Meta) had one of the largest and most anticipated IPOs in history on May 18, 2012, but it failed to meet expectations. A NASDAQ glitch cost investors.
Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized initial ...